Prevalence of the FVQ506 Mutation in the Hellenic Population

Thromb Haemost 1996; 76(01): 127
DOI: 10.1055/s-0038-1650537

Letters to the Editor

Schattauer GmbH Stuttgart

C Chaida

The Second Regional Blood Transfusion Center of Athens, Haemophilia Treatment Center, University Hospital Laikon, Athens, Greece

,

A Gialeraki

The Second Regional Blood Transfusion Center of Athens, Haemophilia Treatment Center, University Hospital Laikon, Athens, Greece

,

C Tsoukala

The Second Regional Blood Transfusion Center of Athens, Haemophilia Treatment Center, University Hospital Laikon, Athens, Greece

,

T Mandalaki

The Second Regional Blood Transfusion Center of Athens, Haemophilia Treatment Center, University Hospital Laikon, Athens, Greece

References
1 Bertina MR, Koeleman PCB, Koster T, Rosendaal RF, Dirven JR, de Ronde H, van der Velden AP, Reitsma HP. Mutation in blood coagulation factor V associated with resistance to activated protein C. Nature 1994; 369: 64-67
2 Dahlbäck B. Resistance to activated protein C, the Arg506 to Gin mutation in the factor V gene, and venous thrombosis. Thromb Haemost 1995; 73: 739-742
3 de Ronde H, Bertina MR. Laboratory diagnosis of APC-resistance: A critical evaluation of the test and the development of diagnostic criteria. Thromb Haemost 1994; 72: 880-886
4 Kollia P, Karababa P, Sinopoulou K, Voskaridou E, Boussiou M, Papadakis M, Loukopoulos D. β-thalassaemia mutations and the underlying β gene cluster haplotypes in the greek population. Gene Geography 1992; 6: 59-70
5 Beauchamp N, Daly M, Hampton K, Cooper P, Preston E, Peake I. High prevalence of a mutation in the factor V gene within the UK population: Relationship to activated protein C resistance and familial thrombosis. BrJHaem 1994; 88: 219-222
6 Svensson JP, Dahlbäck B. Resistance to activated protein C as a basis for venous thrombosis. N Engl J Med 1994; 330: 5517-5522